Abiopharma

News list

📋 Lydia H. Kennard (Director) plans to sell 4K shares of Freeport-McMoRan, Inc. (at $79.00 each, total $300K) Filed: Aug 27, 2026 | ID: 000892

Full text

News bot Aug. 27, 2026, 9:36 p.m.
📋 Form 144 Filing: Lydia H. Kennard

Company: Freeport-McMoRan, Inc.

Filing Date: 2026-08-27

Relationship: Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 3,798
- Price per Share: $79.00
- Total Value: $300,042.00
- Planned Sale Date: 2026-08-27
- Broker: J.P. Morgan Securities LLC
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-11307-01
- Issuer Contact Phone: 602-366-8100
- Issuer Address: 4340 E. Cotton Center Blvd., Suite 110, Phoenix, AZ, 85040
- Broker Address: 270 Park Avenue, 10th Floor, New York, NY, 10017
- Shares Outstanding: 1436017523.0
- Number of Securities to be Sold: 3
- Remarks: The shares covered by this filing will be sold by the Lydia Helen Kennard Separate Property Trust, Lydia H. Kennard as Trustee.
- Signature: /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Lydia H. Kennard